GLSI

Greenwich LifeSciences Inc

1 day chart

About GLSI

Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 will be delivered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce GP2 peptide-specific immunity. GP2 treatment is administered via an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. The Company's Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells while not affecting normal cells or to deliver certain immune system components to inhibit the spread of cancer.

Buy US stocks in Australia starting with GLSI. Open an account and start investing today!

Market Capitalisation

$113.19M

Price-earnings ratio

Dividend yield

0.00%

Volume

9.25K

High today

$8.99

Low today

$8.75

Open price

$8.99

52-week high

$21.50

52-week low

$8.52

GLSI FAQs

Can I buy GLSI shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy GLSI shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Greenwich LifeSciences Inc?

One share of Greenwich LifeSciences Inc is valued at $9.80.

What is the ticker symbol for Greenwich LifeSciences Inc?

The ticker symbol for Greenwich LifeSciences Inc is GLSI.

How do I buy GLSI shares in Australia?

To buy GLSI stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in GLSI

What is the 52-week high for Greenwich LifeSciences Inc stock?

The Greenwich LifeSciences Inc 52-week high stock price is $21.50.

What is the 52-week low for Greenwich LifeSciences Inc stock?

The Greenwich LifeSciences Inc 52-week low stock price is $8.52.

What is the market capitalisation of Greenwich LifeSciences Inc GLSI?

As of 24/09/2023 Greenwich LifeSciences Inc has a market cap of $113M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.